Martin Frejno

Martin Frejno began their work experience as a Werkstudent at Bayer Crop Science in 2008. Martin then worked as a Student Teaching Assistant at Universität zu Köln from 2008 to 2009. In 2011, they worked as a Student Intern at Bayer Pharmaceuticals. From 2012 to 2012, Martin served as a Graduate Student Research Assistant at Rheinische Friedrich-Wilhelms-Universität Bonn. Martin then joined Technische Universität München in 2016 as a Bioinformatician until 2019. In 2019, Martin became the Co-Founder and Chief Executive Officer of MSAID.

Martin Frejno completed their Abitur degree at Norbert Gymnasium Knechtsteden from 1997 to 2006. Martin then pursued a Bachelor of Science degree in Biologie, allgemein at the University of Cologne from 2007 to 2010. Following this, they furthered their education at The University of Bonn, where they obtained a Master of Science degree in Life and Medical Sciences from 2010 to 2012. Finally, Martin completed their highest level of education at the University of Oxford, earning a DPhil (PhD) degree in Oncology from 2012 to 2016.